HK195495A - Novel the compositions - Google Patents

Novel the compositions

Info

Publication number
HK195495A
HK195495A HK195495A HK195495A HK195495A HK 195495 A HK195495 A HK 195495A HK 195495 A HK195495 A HK 195495A HK 195495 A HK195495 A HK 195495A HK 195495 A HK195495 A HK 195495A
Authority
HK
Hong Kong
Prior art keywords
leu
pro
novel
phe
asp
Prior art date
Application number
HK195495A
Other languages
English (en)
Inventor
Nathan Trainin
Yigal Burstein
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of HK195495A publication Critical patent/HK195495A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/065—Thymic humoral factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/18—Thymus derived hormone or factor; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK195495A 1985-06-06 1995-12-28 Novel the compositions HK195495A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/741,753 US4621135A (en) 1983-12-08 1985-06-06 Novel THF compositions

Publications (1)

Publication Number Publication Date
HK195495A true HK195495A (en) 1996-01-05

Family

ID=24982034

Family Applications (1)

Application Number Title Priority Date Filing Date
HK195495A HK195495A (en) 1985-06-06 1995-12-28 Novel the compositions

Country Status (16)

Country Link
US (1) US4621135A (de)
EP (1) EP0204328B1 (de)
JP (2) JPS6248698A (de)
KR (1) KR900003095B1 (de)
AT (1) ATE110389T1 (de)
AU (1) AU569193B2 (de)
CA (1) CA1270597A (de)
CZ (1) CZ419491A3 (de)
DE (2) DE3650035T2 (de)
DK (1) DK262986A (de)
ES (6) ES8801322A1 (de)
HK (1) HK195495A (de)
IL (1) IL78951A (de)
NZ (1) NZ216316A (de)
SK (1) SK419491A3 (de)
ZA (1) ZA863848B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
US6066622A (en) * 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
MX339762B (es) * 2011-09-28 2016-05-27 Univ Autonoma Del Estado De Morelos Metalopeptidos inmunomoduladores (immp) y composiciones que los contienen.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4881838A (de) * 1972-02-15 1973-11-01
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
NL7502830A (nl) * 1974-03-25 1975-09-29 Jean Francois Bach En Dr Jean Werkwijze voor het isoleren van een polypeptide hormoon.
IL47645A (en) * 1975-07-04 1980-10-26 Yeda Res & Dev Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it
DE2732587A1 (de) * 1976-09-22 1978-03-23 Bach Jean Francois Polypeptid mit thymischer wirksamkeit
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
US4275153A (en) * 1978-08-03 1981-06-23 American Hospital Supply Corporation Analytical fluorogenic substrates for proteolytic enzymes
SE448605B (sv) * 1980-10-27 1987-03-09 Vtoroi Mo G Med I Imen Terapeutiskt preparat for reglering av t-immunsystemet och forfarande for framstellning derav
US4374828A (en) * 1980-11-17 1983-02-22 Board Of Reagents, The University Of Texas System Biologically active thymones from the thymus
IT1148005B (it) * 1981-04-09 1986-11-26 Leonida Grippa Tripeptide nelle sue sei combinazioni amminoacide alania fenilalanina e leucina in particolare fenil-alanina-alanina-leucina (p-a-l) aventela proprieta' di esaltare l'immunita' antivirale ed antitumorale
US4505898A (en) * 1982-04-21 1985-03-19 Marks Robert E Derivatives of acetylsalicylic acid and substituted phenylacetic acids and compositions containing them

Also Published As

Publication number Publication date
ES8801322A1 (es) 1987-12-16
DE3650035T2 (de) 1995-03-23
CA1270597A (en) 1990-06-19
EP0204328B1 (de) 1994-08-24
ES557736A0 (es) 1987-12-16
JPH0210160B2 (de) 1990-03-06
KR870000357A (ko) 1987-02-18
IL78951A0 (en) 1986-09-30
ES557737A0 (es) 1987-12-16
EP0204328A2 (de) 1986-12-10
DK262986A (da) 1986-12-07
ES8801316A1 (es) 1987-12-16
ES557740A0 (es) 1987-12-16
ATE110389T1 (de) 1994-09-15
ES8801315A1 (es) 1987-12-16
DE204328T1 (de) 1987-11-05
EP0204328A3 (en) 1988-07-27
ZA863848B (en) 1987-12-30
CZ419491A3 (en) 1993-03-17
AU569193B2 (en) 1988-01-21
ES557739A0 (es) 1988-01-01
JPH01156997A (ja) 1989-06-20
SK419491A3 (en) 1995-07-11
ES555737A0 (es) 1987-12-16
AU5833686A (en) 1987-01-08
DK262986D0 (da) 1986-06-04
ES557738A0 (es) 1987-12-16
ES8801307A1 (es) 1987-12-16
DE3650035D1 (de) 1994-09-29
JPH0422919B2 (de) 1992-04-20
US4621135A (en) 1986-11-04
ES8801308A1 (es) 1987-12-16
ES8801317A1 (es) 1988-01-01
KR900003095B1 (ko) 1990-05-07
JPS6248698A (ja) 1987-03-03
NZ216316A (en) 1991-11-26
IL78951A (en) 1990-11-05

Similar Documents

Publication Publication Date Title
ZA858328B (en) Peptides selected from amino acid residues 11 to 23 of vip
EP0265213A3 (en) Peptide preparations
EP0217634A3 (en) Sequencing of peptides
CA2137378A1 (en) D-enzyme compositions and methods of their use
NO940299D0 (no) peptid med organbestkyttende aktivitet
IL84268A (en) Amino-cyclohexyl-hydroxyalkanoic acid peptide derivatives and pharmaceutical compositions containing them
HK195495A (en) Novel the compositions
ZA867887B (en) Peptides comprising,in sequence units selected from the aminoacid residues 17 to 24 of vip
ZA896980B (en) Peptide compounds
ATE182900T1 (de) Mutierte form von dem beta-amyloidprecursor proteine gen
AU6518486A (en) Peptides and compositions
DE3782006D1 (en) Peptide.
EP0298732A3 (en) Therapeutic somatostatin analogues
EP0317279A3 (de) Peptide für die Verwendung zur Reinigung von Faktor-VIII
ZA877825B (en) "peptide preparations"
AU590536B2 (en) Retro-inverso analogs of the bradykinin potentiating peptide bpp5a
GB2180746B (en) Compositions for administering biologically active peptides via mucous membranes
EP0342015A3 (de) Peptide, deren Benutzung und sie enthaltende pharmazeutische Zusammensetzungen
HUT37109A (en) Process for the phosphinoylation of amino gropus of amino-acids, peptides and esters thereof
ZA874001B (en) Functional recombinant analog polypeptides devoid of hydrophobic amino acids
CA1267086C (en) METHOD OF ADMINISTRATION OF EAR DIURETIC PEPTIDES

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)